Home
  >  
Section 13
  >  
Chapter 12,918

Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion

Ishibashi, D.; Yamanaka, H.; Yamaguchi, N.; Yoshikawa, D.; Nakamura, R.; Okimura, N.; Yamaguchi, Y.; Shigematsu, K.; Katamine, S.; Sakaguchi, S.

Vaccine 25(6): 985-992

2007

ISSN/ISBN: 0264-410X
PMID: 17055125
DOI: 10.1016/j.vaccine.2006.09.078
Accession: 012917468
Download citation:  
Text
  |  
BibTeX
  |  
RIS
Host tolerance to endogenous prion protein (PrP) has hampered the development of prion vaccines as PrP is a major component of prions. Indeed, we show that immunization of mice with mouse recombinant PrP elicited no prophylactic effect against a mouse-adapted prion. However, interestingly, mice immunized with recombinant bovine PrP developed the disease significantly later than non-immunized mice after inoculation of a mouse prion. Sheep recombinant PrP exhibited variable prophylactic effects. Mouse recombinant PrP stimulated only very weak antibody responses. In contrast, bovine recombinant PrP was higher immunogenic and produced variable amounts of anti-mouse PrP autoantibodies. Sheep recombinant PrP was also immunogenic but produced more variable amounts of anti-PrP autoantibodies. These results might open a new way for development of prion vaccines.

PDF emailed within 0-6 h: $19.90




Related References

Serra, F.; Dudas, S.; Torres, J.M.; Anderson, R.; Oevermann, A.; Espinosa, J.C.; Czub, S.; Seuberlich, T. 2018: Presumptive BSE cases with an aberrant prion protein phenotype in Switzerland, 2011: Lack of prion disease in experimentally inoculated cattle and bovine prion protein transgenic mice Transboundary and Emerging Diseases 65(5): 1348-1356
Cappai, R.; Stewart, L.; Jobling, M.F.; Thyer, J.M.; White, A.R.; Beyreuther, K.; Collins, S.J.; Masters, C.L.; Barrow, C.J. 1999: Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation Biochemistry 38(11): 3280-3284
Nakaoke, R.; Sakaguchi, S.; Atarashi, R.; Nishida, N.; Arima, K.; Shigematsu, K.; Katamine, S. 2000: Early appearance but lagged accumulation of detergent-insoluble prion protein in the brains of mice inoculated with a mouse-adapted Creutzfeldt-Jakob disease agent Cellular and Molecular Neurobiology 20(6): 717-730
Sakaguchi, S.; Katamine, S.; Shigematsu, K.; Nakatani, A.; Moriuchi, R.; Nishida, N.; Kurokawa, K.; Nakaoke, R.; Sato, H.; Jishage, K. 1995: Accumulation of proteinase K-resistant prion protein (PrP) is restricted by the expression level of normal PrP in mice inoculated with a mouse-adapted strain of the Creutzfeldt-Jakob disease agent Journal of Virology 69(12): 7586-7592
Sigurdsson, E.M.; Brown, D.R.; Daniels, M.; Kascsak, R.J.; Kascsak, R.; Carp, R.; Meeker, H.C.; Frangione, B.; Wisniewski, T. 2002: Immunization delays the onset of prion disease in mice American Journal of Pathology 161(1): 13-17
Telling, G.C.; Scott, M.; Schatzl, H.; Foster, D.; Yang, S.L.; Torchia, M.; Cohen, F.E.; Dearmond, S.J.; Prusiner, S.B. 1994: Prion transmission from humans to transgenic mice expression chimeric human mouse prion protein provides evidence for a species-specific factor in prion propagation Molecular Biology of the Cell 5(Suppl ): 473A
Gilch, S.; Winklhofer, K.F.; Groschup, M.H.; Nunziante, M.; Lucassen, R.; Spielhaupter, C.; Muranyi, W.; Riesner, D.; Tatzelt, J.; Schätzl, H.M. 2001: Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease EMBO Journal 20(15): 3957-3966
Nishida, N.; Tremblay, P.; Sugimoto, T.; Shigematsu, K.; Shirabe, S.; Petromilli, C.; Erpel, S.P.; Nakaoke, R.; Atarashi, R.; Houtani, T.; Torchia, M.; Sakaguchi, S.; DeArmond, S.J.; Prusiner, S.B.; Katamine, S. 1999: A mouse prion protein transgene rescues mice deficient for the prion protein gene from purkinje cell degeneration and demyelination Laboratory Investigation; a Journal of Technical Methods and Pathology 79(6): 689-697
Miyamoto, K.; Nakamura, N.; Aosasa, M.; Nishida, N.; Yokoyama, T.; Horiuchi, H.; Furusawa, S.; Matsuda, H. 2005: Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein Biochemical and Biophysical Research Communications 335(1): 197-204
Sasaki, K.; Minaki, H.; Iwaki, T. 2009: Development of oligomeric prion-protein aggregates in a mouse model of prion disease Journal of Pathology 219(1): 123-130
Griffin, J.K.; Terry, L.A.; Jackman, R.; Yousefi, M.; Cashman, N.R. 2007: Decreased cell surface prion protein in mouse models of prion disease Neuroreport 18(1): 1-6
Saá, P.; Yakovleva, O.; de Castro, J.; Vasilyeva, I.; De Paoli, S.H.; Simak, J.; Cervenakova, L. 2014: First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification Journal of Biological Chemistry 289(42): 29247-29260
Murakami, K.; Nishikawa, F.; Noda, K.; Yokoyama, T.; Nishikawa, S. 2008: Anti-bovine prion protein RNA aptamer containing tandem GGA repeat interacts both with recombinant bovine prion protein and its beta isoform with high affinity Prion 2(2): 73-80
Nishida, N.; Harris, D.A.; Vilette, D.; Laude, H.; Frobert, Y.; Grassi, J.; Casanova, D.; Milhavet, O.; Lehmann, S. 2000: Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein Journal of Virology 74(1): 320-325
Telling, G.C.; Mastrianni, J.A.; Dearmond, S.J.; Prusiner, S.B. 1996: Exploring mechanisms of prion propagation using mice expressing human and chimeric mouse/human prion protein transgenes Neurology 46(2 Suppl): A251
Otero, A.; Hedman, C.; Fernández-Borges, N.; Eraña, H.; Marín, B.én.; Monzón, M.; Sánchez-Martín, M.A.; Nonno, R.; Badiola, J.J.é; Bolea, R.; Castilla, J.ín. 2019: A Single Amino Acid Substitution, Found in Mammals with Low Susceptibility to Prion Diseases, Delays Propagation of two Prion Strains in Highly Susceptible Transgenic Mouse Models Molecular Neurobiology 56(9): 6501-6511
Panza, G.; Stöhr, J.; Dumpitak, C.; Papathanassiou, D.; Weiss, J.ür.; Riesner, D.; Willbold, D.; Birkmann, E. 2008: Spontaneous and BSE-prion-seeded amyloid formation of full length recombinant bovine prion protein Biochemical and Biophysical Research Communications 373(4): 493-497
Dervishi, E.; Lam, T.H.; Dunn, S.M.; Zwierzchowski, G.; Saleem, F.; Wishart, D.S.; Ametaj, B.N. 2015: Recombinant mouse prion protein alone or in combination with lipopolysaccharide alters expression of innate immunity genes in the colon of mice Prion 9(1): 59-73
Schröder, B.; Groschup, M.; Hunsmann, G.; Bodemer, W. 1998: A differentially expressed prion gene mRNA is found in prion-infected mouse brains and in N2A cells but not in uninfected mice Biochemical and Biophysical Research Communications 251(2): 423-428
Pan, C.; Yang, J.; Zhang, X.; Chen, Y.; Wei, S.; Yu, G.; Pan, Y.-H.; Ma, J.; Yuan, C. 2020: Oral Ingestion of Synthetically Generated Recombinant Prion Is Sufficient to Cause Prion Disease in Wild-Type Mice Pathogens 9(8)